Population Pharmacokinetics and Pharmacodynamics of GSK961081 (Batefenterol), a Muscarinic Antagonist and β2-Agonist, in Moderate-to-Severe COPD Patients: Substudy of a Randomized Trial.

Saved in:

Bibliographic Details
Title:	Population Pharmacokinetics and Pharmacodynamics of GSK961081 (Batefenterol), a Muscarinic Antagonist and β2-Agonist, in Moderate-to-Severe COPD Patients: Substudy of a Randomized Trial.
Authors:	Ambery, Claire L.¹ claire.l.ambery@gsk.com, Wielders, Pascal², Ludwig-Sengpiel, Andrea³, Chan, Robert¹, Riley, John H.¹
Source:	Drugs in R&D. Sep2015, Vol. 15 Issue 3, p281-291. 11p.
Database:	Academic Search Ultimate

Description
ISSN:	11745886
DOI:	10.1007/s40268-015-0104-x